Literature DB >> 20809060

Who waits for inpatient rehabilitation services in Canada after neurotrauma? A population based-study.

Angela Colantonio1, Gary Gerber, Mark Bayley, Raisa Deber, Hwan Kim, Junlang Yin.   

Abstract

OBJECTIVE: This study examined characteristics of patients with acquired brain injury associated with wait times for inpatient rehabilitation compared with a control population of patients with acquired spinal cord injury.
METHODS: This cross-sectional study was based on 9458 patients captured in the National Rehabilitation Reporting System in Canada.
RESULTS: Waiting for inpatient rehabilitation was found to be associated with language, geographical location, informal support, pre-admission living arrangement and payer source. The median differences in wait time, however, were at most a few days. Persons already receiving care had the longest median wait times.
CONCLUSION: The data reflect only the perspective of providers, and further research needs to examine days to inpatient admission using data from acute care.

Entities:  

Mesh:

Year:  2010        PMID: 20809060     DOI: 10.2340/16501977-0582

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  3 in total

1.  Determining level of care appropriateness in the patient journey from acute care to rehabilitation.

Authors:  Christopher J Poulos; Christopher Magee; Guy Bashford; Kathy Eagar
Journal:  BMC Health Serv Res       Date:  2011-10-31       Impact factor: 2.655

2.  Sex-Specific Predictors of Inpatient Rehabilitation Outcomes After Traumatic Brain Injury.

Authors:  Vincy Chan; Tatyana Mollayeva; Kenneth J Ottenbacher; Angela Colantonio
Journal:  Arch Phys Med Rehabil       Date:  2016-02-01       Impact factor: 3.966

3.  Factors associated with discharge destination from acute care after acquired brain injury in Ontario, Canada.

Authors:  Amy Y Chen; Brandon Zagorski; Daria Parsons; Rika Vander Laan; Vincy Chan; Angela Colantonio
Journal:  BMC Neurol       Date:  2012-03-24       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.